A few studies also included the impacts of use and/or disposal of pharmaceutical products. For instance, Goulet et al. (2017) assessed the cradle-to-use carbon footprint of a HFC-134a inhaler and a nebuliser, reporting that the use stage caused the majority of the impact of the inhaler (98%) and nebuliser (60% for hand washed and 40% for using a dishwasher).
การแปล กรุณารอสักครู่..
